SGLT2 inhibitors to prevent diabetic kidney disease

被引：1
|
作者：
Fioretto, Paola [1 ]
Vettor, Roberto [1 ]
Pontremoli, Roberto [2 ,3 ]
机构：
[1] Univ Padua, Dept Med, I-35128 Padua, Italy
[2] Univ Genoa, Dept Internal Med, Genoa, Italy
[3] IRCCS Osped Policlin San Martino, Genoa, Italy
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 01期
关键词：
GLUCOSE-LOWERING DRUGS; CVD-REAL; OUTCOMES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [31] SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
    Klen, Jasna
    Dolzan, Vita
    [J]. PHARMACEUTICS, 2023, 15 (07)
  • [32] Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
    Su Jin Jeong
    Seung Eun Lee
    Dong Hyun Shin
    Ie Byung Park
    Hui Seung Lee
    Kyoung-Ah Kim
    [J]. BMC Nephrology, 22
  • [33] Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease
    Makawi, Alaa T.
    Tawfik, Yahya M. K.
    Dixon, Dave L.
    McMahon, Gearoid M.
    Buckley, Leo F.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 417 - 420
  • [34] Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors
    Guo, Wenwen
    Li, Han
    Li, Yixuan
    Kong, Wen
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [35] Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
    Jeong, Su Jin
    Lee, Seung Eun
    Shin, Dong Hyun
    Park, Ie Byung
    Lee, Hui Seung
    Kim, Kyoung-Ah
    [J]. BMC NEPHROLOGY, 2021, 22 (01)
  • [36] The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy
    Matthews, Jennifer Rose
    Schlaich, Markus P.
    Rakoczy, Elizabeth Piroska
    Matthews, Vance Bruce
    Herat, Lakshini Yasaswi
    [J]. BIOMEDICINES, 2022, 10 (03)
  • [37] Diabetic ketosis/ketoacidosis with SGLT2 inhibitors
    [J]. Reactions Weekly, 2019, 1754 (1) : 5 - 5
  • [38] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Zohaib Yousaf
    Fateen Ata
    Adeel Ahmad Khan
    Almurtada Razok
    Jaweria Akram
    Elrazi Awadelkarim Hamid Ali
    Ahmed Abdalhadi
    Mohammed I. Danjuma
    Dabia Hamad S. H. Al Mohanadi
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 1431 - 1433
  • [39] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Yousaf, Zohaib
    Ata, Fateen
    Khan, Adeel Ahmad
    Razok, Almurtada
    Akram, Jaweria
    Ali, Elrazi Awadelkarim Hamid
    Abdalhadi, Ahmed
    Danjuma, Mohammed I.
    Al Mohanadi, Dabia Hamad S. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1431 - 1433
  • [40] SGLT2 inhibitors and diabetic retinopathy progression
    Nadelmann, Jennifer Beth
    Miller, Charles G.
    McGeehan, Brendan
    Yu, Yinxi
    VanderBeek, Brian L.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
12345